Anti-BNIP3 monoclonal antibody

Pre-made anti-BNIP3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to BNIP3/BNIP3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0426-Ab-1/ GM-Tg-hg-IP0426-Ab-2Anti-Human BNIP3 monoclonal antibodyHuman
GM-Tg-rg-IP0426-Ab-1/ GM-Tg-rg-IP0426-Ab-2Anti-Rat BNIP3 monoclonal antibodyRat
GM-Tg-mg-IP0426-Ab-1/ GM-Tg-mg-IP0426-Ab-2Anti-Mouse BNIP3 monoclonal antibodyMouse
GM-Tg-cynog-IP0426-Ab-1/ GM-Tg-cynog-IP0426-Ab-2Anti-Cynomolgus/ Rhesus macaque BNIP3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0426-Ab-1/ GM-Tg-felg-IP0426-Ab-2Anti-Feline BNIP3 monoclonal antibodyFeline
GM-Tg-cang-IP0426-Ab-1/ GM-Tg-cang-IP0426-Ab-2Anti-Canine BNIP3 monoclonal antibodyCanine
GM-Tg-bovg-IP0426-Ab-1/ GM-Tg-bovg-IP0426-Ab-2Anti-Bovine BNIP3 monoclonal antibodyBovine
GM-Tg-equg-IP0426-Ab-1/ GM-Tg-equg-IP0426-Ab-2Anti-Equine BNIP3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0426-Ab-1/ GM-Tg-hg-IP0426-Ab-2; GM-Tg-rg-IP0426-Ab-1/ GM-Tg-rg-IP0426-Ab-2;
GM-Tg-mg-IP0426-Ab-1/ GM-Tg-mg-IP0426-Ab-2; GM-Tg-cynog-IP0426-Ab-1/ GM-Tg-cynog-IP0426-Ab-2;
GM-Tg-felg-IP0426-Ab-1/ GM-Tg-felg-IP0426-Ab-2; GM-Tg-cang-IP0426-Ab-1/ GM-Tg-cang-IP0426-Ab-2;
GM-Tg-bovg-IP0426-Ab-1/ GM-Tg-bovg-IP0426-Ab-2; GM-Tg-equg-IP0426-Ab-1/ GM-Tg-equg-IP0426-Ab-2
Products NameAnti-BNIP3 monoclonal antibody
Formatmab
Target NameBNIP3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-BNIP3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0426-Ag-1Recombinant multi-species BNIP3/ NIP3 protein
    ORF Viral VectorvGMAD000162human BNIP3 Adenovirus particle
    ORF Viral VectorvGMLPm004024mouse BNIP3 Lentivirus particle
    ORF Viral VectorpGMAD000162human BNIP3 Adenovirus plasmid
    ORF Viral VectorpGMLPm004024mouse BNIP3 Lentivirus plasmid
    ORF Viral VectorpGMLPm000005mouse Bnip3 Lentivirus plasmid
    ORF Viral VectorvGMLPm000005mouse Bnip3 Lentivirus particle


    Target information

    Target IDGM-IP0426
    Target NameBNIP3
    Gene ID664,12176,84480,100426120,607408,768094,615342,100051673
    Gene Symbol and SynonymsBNIP3,HABON,NIP3
    Uniprot AccessionQ12983,Q32KN2
    Uniprot Entry NameBNIP3_HUMAN,BNIP3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000176171
    Target ClassificationTumor-associated antigen (TAA)

    The target: BNIP3, gene name: BNIP3, also named as NIP3. This gene is encodes a mitochondrial protein that contains a BH3 domain and acts as a pro-apoptotic factor. The encoded protein interacts with anti-apoptotic proteins, including the E1B 19 kDa protein and Bcl2. This gene is silenced in tumors by DNA methylation. [provided by RefSeq, Dec 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.